Application of the Next-Generation Sequencing Technology to Reveal Mechanism of Small Cell Lung Cancer Transformation from Adenocarcinoma
To the Editor: Small cell lung cancer (SCLC) transformation is one of the most common mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-SCLC (NSCLC). [1] In this study, we performed next-generation sequencing (NGS) with a panel of 168 tumor ge...
Saved in:
Published in | Chinese medical journal Vol. 131; no. 9; pp. 1124 - 1125 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
China
Wolters Kluwer India Pvt. Ltd
05.05.2018
Medknow Publications and Media Pvt. Ltd Lippincott Williams & Wilkins Ovid Technologies Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China Medknow Publications & Media Pvt Ltd Wolters Kluwer |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To the Editor: Small cell lung cancer (SCLC) transformation is one of the most common mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-SCLC (NSCLC). [1] In this study, we performed next-generation sequencing (NGS) with a panel of 168 tumor genes for consecutive repeat biopsy tissue samples of a lung adenocarcinoma patient harboring EGFR exon 19 deletion (ex19del). In a nonsmoking 26-year-old female patient with chest pain, computed tomography (CT) scan revealed a right lung mass and pleural effusion. |
---|---|
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 |
ISSN: | 0366-6999 2542-5641 |
DOI: | 10.4103/0366-6999.230720 |